Search
Displaying 931–940 of 1028 results
-
ARVO 2016: ProgSTAR, FFB-CRI's Stargardt Disease Patient Study, Highlighted
Research NewsWhen the study and the reports are completed, the ProgSTAR database will be made available to researchers and companies developing therapies.
-
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Research NewsFive of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
-
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
Foundation NewsDavid Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
-
Two New Videos Highlight the Foundation's Vital Role in Retinal Research
Research NewsDr. Shannon Boye and her Foundation-funded research is the subject of not just one but two new Foundation videos.
-
Retinal Researchers May Be Looking for You
Research NewsIf you have a heritable retinal disease, consider registering with My Retina Tracker, the Foundation’s free, secure and confidential registry for people with inherited retinal diseases.
-
Past Sun Exposure Increases AMD Risk
Research NewsResearchers from the University of Cologne in Germany and Radboud University in the Netherlands found that increased sunlight exposure during working life significantly increases risk of AMD later in life.
-
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
Research NewsA Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
-
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In the PressIn a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
-
A Surprising Number of Carrier Females are Affected by X-Linked Retinitis Pigmentosa
Research News40 percent of genetically tested XLRP carriers showed a definitive abnormality in at least one of three visions tests.
-
First AMD Patient Receives Argus II Bionic Retina
Research NewsA pioneering, 80-year-old named Ray Flynn is the first AMD patient to receive the Argus II, and he is already reporting that he can see things better in his garden.
